Evidence map›Paper›PMID 29380177›Full record

SynthesisHeart failure reviews2018

Prophylactic use of the implantable cardioverter-defibrillator and its effect on the long-term survival, cardiovascular and sudden cardiac death in nonischemic cardiomyopathy patients-a systematic review and meta-analysis.

Waqas Javed Siddiqui, Sandeep Aggarwal, Muhammad Rafique, Swaiman Singh, Steven Kutalek, Howard J Eisen

Abstract readMeta-AnalysisSystematic Review
PubMed Publisher
In one paragraph

Synthesis in Heart failure reviews, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 2 pooled it
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 2 syntheses or guidelines pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Does the heart transplant have a future?European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery · 2019
    Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Waqas Javed SiddiquiDepartment of Medicine, Drexel University College of Medicine, 245 N. 15th Street, NCB Suite 6144, Philadelphia, PA, 19102, USA. dr.waqas20@gmail.com.
Sandeep AggarwalDepartment of Medicine, Drexel University College of Medicine, 245 N. 15th Street, NCB Suite 6144, Philadelphia, PA, 19102, USA.
Muhammad RafiqueDepartment of Medicine, Seton Hall University, St. Francis Medical Center, Trenton, NJ, USA.
Swaiman SinghDepartment of Medicine, Drexel University College of Medicine, 245 N. 15th Street, NCB Suite 6144, Philadelphia, PA, 19102, USA.
Steven KutalekDepartment of Medicine, Drexel University College of Medicine, 245 N. 15th Street, NCB Suite 6144, Philadelphia, PA, 19102, USA.
Howard J EisenDepartment of Medicine, Drexel University College of Medicine, 245 N. 15th Street, NCB Suite 6144, Philadelphia, PA, 19102, USA.
Drexel University · USHahnemann University Hospital · USSt. Francis Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Implantable cardioverter-defibrillator (ICD) has shown to reduce sudden cardiac death and overall mortality in patients with dilated cardiomyopathy. The recently published DANISH trial has shown conflicting outcomes on the long-term survival in patients with prophylactic implantation of ICD in Non-Ischemic Cardiomyopathy (NICM). Two independent reviewers searched MEDLINE, PUBMED, Ovid, CINAHL, clinicaltrials.gov , and Cochrane Registry for randomized control trials (RCT's) comparing ICD to medical treatment (MT). Six RCT's enrolling 3389 patients (ICD = 1554 and MT = 1835) were included for final analysis. The primary outcomes were mortality comparing ICD to MT, 231 vs 337 (OR = 0.74, CI = 0.62-0.90, p = 0.002, and I

Indexed as

CardiomyopathiesDeath, Sudden, CardiacDefibrillators, ImplantableGlobal HealthHumansIncidencePrimary PreventionRisk AssessmentRisk FactorsSurvival RateImplantable cardioverter-defibrillatorMeta-analysisMortalityNonischemic cardiomyopathySudden cardiac deathSurvival

Identifiers

PMID29380177
OpenAlexW2793311021

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.